Molecular Biology Enzymes Market: Asia-Pacific Market to Offer Significant Growth Opportunities


Posted February 16, 2017 by mmvaidya01

This report studies the molecular biology enzymes and kits & reagents market for the forecast period of 2016 to 2021. This market is expected to reach 12.69 Billion by 2021 from USD 5.77 Billion in 2016, growing at a CAGR of 17.1%.

 
Browse 102 market data Tables and 43 Figures spread through 184 Pages and in-depth TOC on "Molecular Biology Enzymes and Kits & Reagents Market"
http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
Early buyers will receive 10% customization on reports.

The global molecular biology enzymes and kits & reagents market is witnessing significant growth and is likely continue to do so over the next five years. Factors such as a technological advancements in the life science industry, increased research activities in the pharmaceutical and biotechnology sector, rising incidences of infectious diseases and genetic disorders, and successful completion of human genome project contribute to the growth of the molecular biology enzymes and kits & reagents market.

In the forecast period, the Asia-Pacific region is projected to grow at the highest CAGR. Growth in this region is likely to be centered at China and India. Countries such as Korea, Australia, and Singapore are also likely to project a medium-to-high growth rate.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=164131709

Asia-Pacific region is expected to witness significant growth in the molecular biology enzymes and kits & reagents market as the healthcare infrastructure in Asia-Pacific is undergoing significant developmental change. Additionally, Asia-Pacific countries are investing in new technologies and solutions while carrying out initiatives to improve their healthcare services. Furthermore, the adoption of advanced technology such sequencing in Asia-Pacific countries for genetic disorder management is increasing.

The overall molecular biology enzymes and kits & reagents market in Asia-Pacific is expected to grow rapidly in the coming years, mainly due to the increasing expansion of market players in this region. Industry players in this market are developing their presence in this market to enhance their share in this highly competitive market.

For instance, in November 2014, Roche invested nearly USD 465 million (CHF 450 million) over next three years to establish a Suzhou Industrial Park in Suzhou, China. The new manufacturing facility is expected to address the growing demand for diagnostic tests in China and Asia Pacific region.

Speak to Research Analyst:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=164131709

Furthermore, in August 2015, Takara Bio, Inc. (Japan) opened a new facility at Kusatsu, Shiga (Japan). The company’s headquarters are also relocated to this new facility. This relocation was expected to enhance the efficiency of R & D activities and provide genetic analysis services. Furthermore, the Indian molecular biology enzymes and kits & reagents market’s growth is attributed to growing pharmaceutical industry backed by government initiatives in India, development of bioclusters in India.

The Korea- U.S. Free Trade Agreement signed in March 2012, is expected to accelerate the expansion of movement of goods and services, thus providing expansion opportunities for market players in Asia-Pacific. In addition, The Genome Asia 100K Initiative, was in February 2016, at the Nanyang Technological University, Singapore. Supporters of this initiative include Medgenome Labs Pvt. Ltd. (India) and Illumina, Inc. (U.S.). Furthermore, the growth of Australian molecular biology enzymes and kits & reagents market is attributed to collaborations and partnerships among various organizations within the region.

About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Biotech , Research , Science
Tags global molecular biology enzymes market , molecular biology enzymes , molecular biology enzymes and kits reagents market , molecular biology enzymes market , molecular biology kits , molecular biology kits market , molecular biology reagents , molecular biology reagents market
Last Updated February 16, 2017